Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer

Epidermal growth factor receptor (EGFR) mutations and anaplastic large-cell lymphoma kinase (ALK) rearrangements are now routine biomarkers that have been incorporated into the practice of managing non-small cell lung cancer (NSCLC). Historically, the two molecular alterations have been viewed as mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sweis, Randy F, Thomas, Sachdev, Bank, Bruce, Fishkin, Paul, Mooney, Colin, Salgia, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807912/
https://www.ncbi.nlm.nih.gov/pubmed/27026837
http://dx.doi.org/10.7759/cureus.513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807912/
https://www.ncbi.nlm.nih.gov/pubmed/27026837
http://dx.doi.org/10.7759/cureus.513

Ejemplares similares